Pyxis Tankers beat estimated earnings by 5.26%, reporting an EPS of $0.2 versus an estimate of $0.19. Revenue was down $1.50 million from the same period last year. During the previous quarter, the ...

Pyxis Tankers Inc (NASDAQ:PXS) reported a solid financial performance with strong revenues and profitability driven by supportive market conditions. The company successfully expanded into the dry-bulk ...

Pyxis Oncology (NASDAQ:PYXS), a biopharmaceutical company specializing in the development of antibody-drug conjugates (ADCs) for cancer treatment, has been garnering attention from investors and ...

Pyxis Tankers Inc (NASDAQ:PXS) chairman and CEO Valentios (Eddie) Valentis speaks to Thomas Warner from Proactive about how the tanker operator has been performing since his last Proactive appearance ...

Discover who owns Pyxis Tankers Inc. Access the ownership overview, view the top Pyxis Tankers Inc shareholders, institutional holders, and leading mutual fund investors. Understand the key ...